Literature DB >> 25052254

Predicting remission of diabetes after RYGB surgery following intensive management to optimize preoperative glucose control.

Thomas MacAndrew English1, Samir Malkani, Rebecca L Kinney, Abdulkadir Omer, Mary Beth Dziewietin, Richard Perugini.   

Abstract

BACKGROUND: The purpose of the study is to investigate the association of preoperative glucose optimization prior to a Roux-en-Y gastric bypass (RYGB) and diabetes remission.
METHODS: The study is a retrospective review of 245 patients with a history of diabetes type II and a RYGB from 2008 to 2012 at UMass Memorial Hospital.
RESULTS: Patients that benefited from glucose optimization prior to RYGB were more likely to achieve diabetes remission 1 year after surgery. The preoperative glucose optimization intervention demonstrated that when patients decreased their HbA1c prior to surgery by 1 %, these individuals were 68 % more likely to remit (p = 0.015). Duration of diabetes (p = 0.005) and insulin use (p < 0.001) were also significant predictors of remission, whereas age, race, and gender were not.
CONCLUSIONS: Our study results indicate that a greater degree of glycemic improvement in response to presurgical medical intervention is associated with higher rates of diabetes remission post-operatively among obese adults with diabetes type II. Conversely, the lack of favorable glycemic response to intensification of medical management predicts a poor glycemic response to bariatric surgery. Further research is needed to determine if this difference is due to physiological factors or is simply an indicator of patient behavior.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25052254     DOI: 10.1007/s11695-014-1339-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  26 in total

1.  Different cycle ergometer outcomes in severely obese men and women without documented cardiopulmonary morbidities before bariatric surgery.

Authors:  Jacqueline G Dolfing; Emile F Dubois; Bruce H R Wolffenbuttel; Nienke M ten Hoor-Aukema; Dave H Schweitzer
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

2.  Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.

Authors:  Numan Hamza; Muhammad Hasan Abbas; Ammar Darwish; Zainab Shafeek; John New; Basil J Ammori
Journal:  Surg Obes Relat Dis       Date:  2010-04-07       Impact factor: 4.734

3.  Practice makes perfect? Patient response to a prebariatric surgery behavior modification program.

Authors:  Dana Brandenburg; Rebecca Kotlowski
Journal:  Obes Surg       Date:  2005-01       Impact factor: 4.129

4.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

5.  Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study.

Authors:  Wei-Jei Lee; Kyung Yul Hur; Muffazal Lakadawala; Kazunori Kasama; Simon K H Wong; Yi-Chih Lee
Journal:  J Gastrointest Surg       Date:  2011-11-01       Impact factor: 3.452

6.  Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial.

Authors:  Ramzi S Alami; John M Morton; Rob Schuster; Jie Lie; Barry R Sanchez; Anna Peters; Myriam J Curet
Journal:  Surg Obes Relat Dis       Date:  2007-02-27       Impact factor: 4.734

7.  Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.

Authors:  Philip R Schauer; Bartolome Burguera; Sayeed Ikramuddin; Dan Cottam; William Gourash; Giselle Hamad; George M Eid; Samer Mattar; Ramesh Ramanathan; Emma Barinas-Mitchel; R Harsha Rao; Lewis Kuller; David Kelley
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

8.  Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults.

Authors:  David Arterburn; Andy Bogart; Karen J Coleman; Sebastien Haneuse; Joe V Selby; Nancy E Sherwood; Stephen Sidney; Mary Kay Theis; Guilherme M Campos; David McCulloch; Patrick J O' Connor
Journal:  Obes Res Clin Pract       Date:  2013 Jul-Aug       Impact factor: 2.288

9.  Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report.

Authors:  Carsten Dirksen; Siv H Jacobsen; Kirstine N Bojsen-Møller; Nils B Jørgensen; Lars S Naver; Lisbeth E Hvolris; Dorte Worm; Sten Madsbad; Jens J Holst; Dorte L Hansen
Journal:  Obes Res Clin Pract       Date:  2013 Jul-Aug       Impact factor: 2.288

10.  Preoperative lifestyle intervention in bariatric surgery: initial results from a randomized, controlled trial.

Authors:  M A Kalarchian; M D Marcus; A P Courcoulas; Y Cheng; M D Levine
Journal:  Obesity (Silver Spring)       Date:  2013-02       Impact factor: 5.002

View more
  4 in total

1.  Clinical effectiveness of exenatide in diabetic patients waiting for bariatric surgery.

Authors:  P Iglesias; S Civantos; B Vega; I Pavón; G Guijarro; S Monereo
Journal:  Obes Surg       Date:  2015-03       Impact factor: 4.129

2.  Do Bariatric Surgery-Related Type 2 Diabetes Remission Predictors Add Clinical Value? A Study on Asian Indian Obese Diabetics.

Authors:  P Praveen Raj; Siddhartha Bhattacharya; S Saravana Kumar; Sandeep C Sabnis; R Parthasarathi; Parimala Devi Kumara Swamy; C Palanivelu
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

3.  Long-term outcomes of laparoscopic sleeve gastrectomy from the Indian subcontinent.

Authors:  Shivanshu Misra; Siddhartha Bhattacharya; S Saravana Kumar; B Deepa Nandhini; S Christinajoice Saminathan; P Praveen Raj
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

4.  Dose response of exercise training following roux-en-Y gastric bypass surgery: A randomized trial.

Authors:  Tracey L Woodlief; Elvis A Carnero; Robert A Standley; Giovanna Distefano; Steve J Anthony; Gabe S Dubis; John M Jakicic; Joseph A Houmard; Paul M Coen; Bret H Goodpaster
Journal:  Obesity (Silver Spring)       Date:  2015-11-05       Impact factor: 5.002

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.